Search CommunityWalk:


Electric Genetics Corporation

11951 Freedom Drive, 13th Floor
Reston, VA, USA

Category: Bioinformatics/Genomics/Proteomics/Pharmacogenomics

Used in the following map:

Maryland Biotech Industry Map

Electric Genetics Corporation is specialized in the field of computational genomics and provides genomic data analysis systems and validated drug targets for the pharmaceutical, biotechnology and genomics market. The company was established in 1997.

Electric Genetics has developed technologies in following areas - accurate and rapid analysis of genomic data, genomic comparisons, relating genotypic behavior to phenotypic characteristics and identifying and validating critical genes in infections diseases. Its products and services include: 1) stackPACK(TM) - a transcript reconstruction and management tool; 2) STACKdb(TM) - a reconstructed human gene index; 3) eVoke(TM) - an expression ontology toolkit and 4) ADAPT(TM) - a revolutionary in-silico technology for the rapid identification of medically important or otherwise specialized genes in any organism.

Electric Genetics provides the ability to clearly relate the relationships between genome, gene expression data and phenotype, through a core of transcriptomic data offerings. These products provide a novel and powerful means to integrate information from clinical genetics, genomics, expression studies and proteomics to link genotypes to humans' physical characteristics and pathologic states and thus boost the discovery process. The company provides specialized services aimed to increase the utility and effectiveness of open source bioinformatics tools through value-added activities such as documentation, validation, packaging, integration and training.

Electric Genetics is entering the drug discovery market by: Developing a portfolio of proprietary drug targets for major pathogens, including: Helicobacter pylori, Streptococcus pneumonia, Staphylococcus aureus, Mycobacterium tuberculosis and the malaria parasite, Plasmodium to be licensed. Establising target discovery collaborations with biotechnology/pharmaceutical companies to leverage the ADAPT(TM) system.

Electric Genetics' partners include: The South African National Bioinformatics Institute (SANBI), Imperial College of Science, Technology and Medicine, Lion Bioscience, Ensembl Project - Sanger Institute, Sygnis Pharma AG, Affymetrix Inc etc.